IL-12 R beta 2 Antibody (305719) [DyLight 680]
Novus Biologicals, part of Bio-Techne | Catalog # FAB19592Y
Conjugate
Catalog #
Key Product Details
Species Reactivity
Human, Mouse
Applications
Direct ELISA
Label
DyLight 680 (Excitation = 692 nm, Emission = 712 nm)
Antibody Source
Monoclonal Mouse IgG1 Clone # 305719
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
Mouse myeloma cell line NS0-derived recombinant human IL-12 R beta2
Cys28-Asn622
Accession # Q99665
Cys28-Asn622
Accession # Q99665
Specificity
Detects human IL-12 R beta2 in ELISA.
Clonality
Monoclonal
Host
Mouse
Isotype
IgG1
Applications for IL-12 R beta 2 Antibody (305719) [DyLight 680]
Application
Recommended Usage
Direct ELISA
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Please Note: Optimal dilutions of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Protein A or G purified from hybridoma culture supernatant
Formulation
50mM Sodium Borate
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: IL-12 R beta 2
Long Name
Interleukin 12 Receptor beta 2
Alternate Names
IL-12Rb2, IL12R beta 2, IL12RB2
Additional IL-12 R beta 2 Products
Product Documents for IL-12 R beta 2 Antibody (305719) [DyLight 680]
Product Specific Notices for IL-12 R beta 2 Antibody (305719) [DyLight 680]
DyLight (R) is a trademark of Thermo Fisher Scientific Inc. and its subsidiaries.
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...